WEST PHARMACEUTICAL SERVICES (WST) Stock Price & Overview

NYSE:WST • US9553061055

Current stock price

235.46 USD
+4.37 (+1.89%)
At close:
235.46 USD
0 (0%)
After Hours:

The current stock price of WST is 235.46 USD. Today WST is up by 1.89%. In the past month the price decreased by -3.35%. In the past year, price increased by 2.32%.

WST Key Statistics

52-Week Range187.43 - 322.34
Current WST stock price positioned within its 52-week range.
1-Month Range228.4 - 254.605
Current WST stock price positioned within its 1-month range.
Market Cap
16.958B
P/E
32.30
Fwd P/E
29.06
EPS (TTM)
7.29
Dividend Yield
0.32%

WST Stock Performance

Today
+1.89%
1 Week
-4.23%
1 Month
-3.35%
3 Months
-12.00%
Longer-term
6 Months -7.12%
1 Year +2.32%
2 Years -40.50%
3 Years -32.04%
5 Years -16.44%
10 Years +239.67%

WST Stock Chart

WEST PHARMACEUTICAL SERVICES / WST Daily stock chart

WST Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to WST. When comparing the yearly performance of all stocks, WST is a bad performer in the overall market: 70.34% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

WST Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to WST. WST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

WST Earnings

On February 12, 2026 WST reported an EPS of 2.04 and a revenue of 805.00M. The company beat EPS expectations (10.24% surprise) and beat revenue expectations (0.33% surprise).

Next Earnings DateApr 22, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported$2.04
Revenue Reported805M
EPS Surprise 10.24%
Revenue Surprise 0.33%

WST Forecast & Estimates

23 analysts have analysed WST and the average price target is 328.99 USD. This implies a price increase of 39.72% is expected in the next year compared to the current price of 235.46.

For the next year, analysts expect an EPS growth of 11.14% and a revenue growth 6.01% for WST


Analysts
Analysts80.87
Price Target328.99 (39.72%)
EPS Next Y11.14%
Revenue Next Year6.01%

WST Groups

Sector & Classification

WST Financial Highlights

Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 7.29. The EPS increased by 8% compared to the year before.


Income Statements
Revenue(TTM)3.07B
Net Income(TTM)493.70M
Industry RankSector Rank
PM (TTM) 16.06%
ROA 11.56%
ROE 15.54%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%12.09%
Sales Q2Q%7.51%
EPS 1Y (TTM)8%
Revenue 1Y (TTM)6.25%

WST Ownership

Ownership
Inst Owners97.62%
Shares72.02M
Float71.36M
Ins Owners0.33%
Short Float %3.13%
Short Ratio2.33

WST Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC18.72172.504B
DHR DANAHER CORP22.06132.461B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28126.6441.658B
A AGILENT TECHNOLOGIES INC16.6731.524B
WAT WATERS CORP19.7228.113B
IQV IQVIA HOLDINGS INC12.8527.652B
MTD METTLER-TOLEDO INTERNATIONAL25.0323.862B
ILMN ILLUMINA INC22.7318.186B
MEDP MEDPACE HOLDINGS INC25.8412.783B
RVTY REVVITY INC15.529.567B
TEM TEMPUS AI INC-CL A N/A8.935B
TECH BIO-TECHNE CORP22.857.955B

About WST

Company Profile

WST logo image West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Company Info

IPO: 1923-07-27

WEST PHARMACEUTICAL SERVICES

530 Herman O. West Drive

Exton PENNSYLVANIA 19341 US

CEO: Eric M. Green

Employees: 10600

WST Company Website

WST Investor Relations

Phone: 18006222300

WEST PHARMACEUTICAL SERVICES / WST FAQ

What does WST do?

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.


What is the current price of WST stock?

The current stock price of WST is 235.46 USD. The price increased by 1.89% in the last trading session.


What is the dividend status of WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.85.


How is the ChartMill rating for WEST PHARMACEUTICAL SERVICES?

WST has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the ex-dividend date for WST stock?

The next ex-dividend date for WEST PHARMACEUTICAL SERVICES (WST) is April 29, 2026.


What is the employee count for WST stock?

WEST PHARMACEUTICAL SERVICES (WST) currently has 10600 employees.


What is the ownership structure of WEST PHARMACEUTICAL SERVICES (WST)?

You can find the ownership structure of WEST PHARMACEUTICAL SERVICES (WST) on the Ownership tab.